The Pharmaceutical API Manufacturing by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Pharmaceutical API Manufacturing Market:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-api-manufacturing-global-market-report
According to The Business Research Company’s Pharmaceutical API Manufacturing, The pharmaceutical api manufacturing market size has grown strongly in recent years. It will grow from $206.95 billion in 2023 to $219.76 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increase in pharmaceutical r&d expenditure, increasing preference for outsourcing apis, growing prevalence of chronic illness, increased healthcare expenditure, a rise in disposable income, an increase in patent expiration and growing government policies for api production. .
The pharmaceutical api manufacturing market size is expected to see strong growth in the next few years. It will grow to $279.03 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to a rise in ageing population, rapid technological advancements, rising prevalence of cancer, increasing mergers and acquisitions and high potential of emerging economies will drive the growth.. Major trends in the forecast period include focus on production facility expansion, use of artificial intelligence (ai), focus on greener api manufacturing, increasing investments and focus on use of qr code labelling. .
The rise in the aging population is one of the major drivers of the pharmaceutical API manufacturing market. As the aging population increases, the demand for pharmaceutical drugs also increases. API acts as a specialty drug in these medicines to cure a particular disease. For instance, in October 2022, according to an article shared by WHO, a Switzerland-based specialized agency of the United Nations responsible for international public health, 80% of senior citizens will reside in low- and middle-income nations by 2050. The population is aging considerably more quickly than in the past. In 2020, there will be more persons over the age of 60 than under five-year-olds. Therefore, the rise in the aging population is driving the growth of the pharmaceutical API manufacturing market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=2467&type=smp
The pharmaceutical api manufacturing market covered in this report is segmented –
1) By Therapy Area: Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Other Therapeutics Uses
2) By API Type: Chemical API, Biological API
3) By Drug Type: Prescription Drugs, Over-The-Counter (OTC) Drugs
Many companies use modern technologies such as process control, and powder handling to optimize API manufacturing. These technologies include advances in Lyophilization i.e., freeze-drying process. It is a low-temperature dehydration process that involves freezing the product, lowering pressure, and then removing the ice formed. For instance, Telstar, a company that manufactures efficient integrated systems for pharmaceutical and manufacturing processes, developed LyoGistics Zero, an automatic loading and unloading system for freeze dryers to manufacture hazardous products. The system uses a linear magnetic driving mechanism that functions without racks and belts to reduce particle generation and this improves the hygiene in API manufacturing. Also, ILC Dover, a pharmaceutical company, developed the JetBreaker system, a semi-automatic powder handling system that separates powdered media and buffers powders so that they can be mixed better in a solution.
The pharmaceutical api manufacturing market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Pfizer Inc.
- Sanofi S.A
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Dr. Reddy’s Laboratories,
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
